Extended effectiveness of the Etonogestrel-releasing contraceptive implant and the 20 ug Levonorgestrel-releasing intrauterine system for 2 years beyond U.S. Food and Drug Administration Product Labeling.
Ali M; Bahamondes L; Landoulsi SB
Global Health: Science and Practice. 2017 Dec; 5(4):534-539.
Region / Country:
Add to my documents. Add to My Documents